{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T05:53:12Z","timestamp":1713246792790},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T00:00:00Z","timestamp":1305244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10072-011-0614-4","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T07:27:20Z","timestamp":1305185240000},"page":"1241-1247","source":"Crossref","is-referenced-by-count":6,"title":["Alzheimer\u2019s disease: ageing-related or age-related? New hypotheses from an old debate"],"prefix":"10.1007","volume":"32","author":[{"given":"Orso","family":"Bugiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,13]]},"reference":[{"key":"614_CR1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C et al (2010) Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol 9:1118\u20131127","journal-title":"Lancet Neurol"},{"key":"614_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0197-4580(00)00211-6","volume":"22","author":"J Joseph","year":"2001","unstructured":"Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA (2001) Copernicus revisited: amyloid beta in Alzheimer\u2019s disease. Neurobiol Aging 22:131\u2013146","journal-title":"Neurobiol Aging"},{"key":"614_CR3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-2008-15408","volume":"15","author":"M Pallas","year":"2008","unstructured":"Pallas M, Camins A, Smith MA, Perry G, Lee HG, Casadesus G (2008) From aging to Alzheimer\u2019s disease: unveiling \u201cthe switch\u201d with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 15:615\u2013624","journal-title":"J Alzheimers Dis"},{"key":"614_CR4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbadis.2006.10.014","volume":"1772","author":"X Zhu","year":"2007","unstructured":"Zhu X, Lee HG, Perry G, Smith MA (2007) Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 1772:494\u2013502","journal-title":"Biochim Biophys Acta"},{"key":"614_CR5","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1242\/jcs.03481","volume":"120","author":"MS Wolfe","year":"2007","unstructured":"Wolfe MS, Gu\u00e9nette SY (2007) APP at a glance. J Cell Sci 120:3157\u20133161","journal-title":"J Cell Sci"},{"key":"614_CR6","first-page":"58406","volume":"2006","author":"DS Wang","year":"2006","unstructured":"Wang DS, Dickson DW, Malter JS (2006) Beta-amyloid degradation and Alzheimer\u2019s disease. J Biomed Biotechnol 2006:58406","journal-title":"J Biomed Biotechnol"},{"key":"614_CR7","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"614_CR8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Thal DR, Arzberger T et al (2009) Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:309\u2013320","journal-title":"Acta Neuropathol"},{"key":"614_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0304-3940(89)90110-9","volume":"103","author":"O Bugiani","year":"1989","unstructured":"Bugiani O, Giaccone G, Frangione B, Ghetti B, Tagliavini F (1989) Alzheimer patients: preamyloid deposits are more widely distributed than senile plaques throughout the central nervous system. Neurosci Lett 103:263\u2013268","journal-title":"Neurosci Lett"},{"key":"614_CR10","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","volume":"27","author":"WE Klunk","year":"2007","unstructured":"Klunk WE, Price JC, Mathis CA et al (2007) Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27:6174\u20136184","journal-title":"J Neurosci"},{"key":"614_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1196\/annals.1377.005","volume":"1086","author":"G Bu","year":"2006","unstructured":"Bu G, Cam J, Zerbinatti C (2006) LRP in amyloid-beta production and metabolism. Ann N Y Acad Sci 1086:35\u201353","journal-title":"Ann N Y Acad Sci"},{"key":"614_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"614_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156720506775697098","volume":"3","author":"J Hardy","year":"2006","unstructured":"Hardy J (2006) Has the amyloid cascade hypothesis for Alzheimer\u2019s disease been proved? Curr Alzheimer Res 3:71\u201373","journal-title":"Curr Alzheimer Res"},{"key":"614_CR14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11064-007-9469-8","volume":"33","author":"R Cappai","year":"2008","unstructured":"Cappai R, Barnham KJ (2008) Delineating the mechanism of Alzheimer\u2019s disease: a beta peptide neurotoxicity. Neurochem Res 33:526\u2013532","journal-title":"Neurochem Res"},{"key":"614_CR15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/35086072","volume":"2","author":"DH Small","year":"2001","unstructured":"Small DH, Mok SS, Bornstein JC (2001) Alzheimer\u2019s disease and Abeta toxicity: from top to bottom. Nat Rev Neurosci 2:595\u2013598","journal-title":"Nat Rev Neurosci"},{"key":"614_CR16","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","volume":"99","author":"M Rapoport","year":"2002","unstructured":"Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99:6364\u20136369","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","volume":"14","author":"J Busciglio","year":"1995","unstructured":"Busciglio J, Lorenzo A, Yeh J, Yankner BA (1995) Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879\u2013888","journal-title":"Neuron"},{"key":"614_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0306-4522(02)00404-9","volume":"115","author":"WH Zheng","year":"2002","unstructured":"Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S (2002) Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115:201\u2013211","journal-title":"Neuroscience"},{"key":"614_CR19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2005.12.134","volume":"1094","author":"E Samura","year":"2006","unstructured":"Samura E, Shoji M, Kawarabayashi T et al (2006) Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1. Brain Res 1094:192\u2013199","journal-title":"Brain Res"},{"key":"614_CR20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487\u20131491","journal-title":"Science"},{"key":"614_CR21","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced bu Abeta42 fibrils. Science 293:1491\u20131495","journal-title":"Science"},{"key":"614_CR22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43:321\u2013332","journal-title":"Neuron"},{"key":"614_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-2009-0960","volume":"16","author":"HC Huang","year":"2009","unstructured":"Huang HC, Jiang ZF (2009) Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer\u2019s disease. J Alzheimers Dis 16:15\u201327","journal-title":"J Alzheimers Dis"},{"key":"614_CR24","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1073\/pnas.0509695103","volume":"103","author":"V Galvan","year":"2006","unstructured":"Galvan V, Gorostiza OF, Banwait S et al (2006) Reversal of Alzheimer\u2019s-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 103:7130\u20137135","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR25","first-page":"79","volume":"148","author":"G Giaccone","year":"1996","unstructured":"Giaccone G, Pedrotti B, Migheli A et al (1996) betaPP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer\u2019s disease. Am J Pathol 148:79\u201387","journal-title":"Am J Pathol"},{"key":"614_CR26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nbd.2004.10.011","volume":"18","author":"C Barbato","year":"2005","unstructured":"Barbato C, Canu N, Zambrano N et al (2005) Interaction of Tau with Fe65 links tau to APP. Neurobiol Dis 18:399\u2013408","journal-title":"Neurobiol Dis"},{"key":"614_CR27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1091\/mbc.E06-04-0283","volume":"18","author":"T M\u00fcller","year":"2007","unstructured":"M\u00fcller T, Concannon CG, Ward MW et al (2007) Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell 18:201\u2013210","journal-title":"Mol Biol Cell"},{"key":"614_CR28","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1212\/WNL.44.9.1593","volume":"44","author":"EM Ebly","year":"1994","unstructured":"Ebly EM, Parhad IM, Hogan DB, Fung TS (1994) Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology 44:1593\u20131600","journal-title":"Neurology"},{"key":"614_CR29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1192\/bjp.166.5.621","volume":"166","author":"MM Fichter","year":"1995","unstructured":"Fichter MM, Meller I, Schr\u00f6ppel H, Steinkirchner R (1995) Dementia and cognitive impairment in the oldest old in the community. Prevalence and comorbidity. Br J Psychiatry 166:621\u2013629","journal-title":"Br J Psychiatry"},{"key":"614_CR30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp.60.6.628","volume":"60","author":"M Prencipe","year":"1996","unstructured":"Prencipe M, Casini AR, Ferretti C, Lattanzio MT, Fiorelli M, Culasso F (1996) Prevalence of dementia in an elderly rural population: effects of age, sex, and education. J Neurol Neurosurg Psychiatry 60:628\u2013633","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"614_CR31","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.51.3.728","volume":"51","author":"AF Jorm","year":"1998","unstructured":"Jorm AF, Jolley D (1998) The incidence of dementia. A meta-analysis. Neurology 51:728\u2013733","journal-title":"Neurology"},{"key":"614_CR32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archneur.56.5.587","volume":"56","author":"E Strauss von","year":"1999","unstructured":"von Strauss E, Viitanen M, De Ronchi D, Winblad B, Fratiglioni L (1999) Aging and the occurrence of dementia. Findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol 56:587\u2013592","journal-title":"Arch Neurol"},{"key":"614_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"614_CR34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"614_CR35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-2009-1143","volume":"18","author":"J G\u00f6tz","year":"2009","unstructured":"G\u00f6tz J, Schonrock N, Vissel B, Ittner LM (2009) Alzheimer\u2019s disease selective vulnerability and modeling in transgenic mice. J Alzheimers Dis 18:243\u2013251","journal-title":"J Alzheimers Dis"},{"key":"614_CR36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(96)01030-2","volume":"20","author":"J Hardy","year":"1997","unstructured":"Hardy J (1997) Amyloid, the presenilins and Alzheimer\u2019s disease. Trends Neurosci 20:154\u2013159","journal-title":"Trends Neurosci"},{"key":"614_CR37","first-page":"282","volume":"7","author":"LC Cork","year":"1990","unstructured":"Cork LC (1990) Neuropathology of Down syndrome and Alzheimer disease. Am J Med Genet Suppl 7:282\u2013286","journal-title":"Am J Med Genet Suppl"},{"key":"614_CR38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G et al (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24\u201326","journal-title":"Nat Genet"},{"key":"614_CR39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH et al (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39:168\u2013177","journal-title":"Nat Genet"},{"key":"614_CR40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/0-387-23226-5_13","volume":"38","author":"DB Carter","year":"2005","unstructured":"Carter DB (2005) The interaction of amyloid-beta with ApoE. Subcell Biochem 38:255\u2013272","journal-title":"Subcell Biochem"},{"key":"614_CR41","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ng1009-1047","volume":"41","author":"MA Es van","year":"2009","unstructured":"van Es MA, van den Berg LH (2009) Alzheimer\u2019s disease beyond APOE. Nat Genet 41:1047\u20131048","journal-title":"Nat Genet"},{"key":"614_CR42","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med 2:864\u2013870","journal-title":"Nat Med"},{"key":"614_CR43","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.febslet.2007.02.026","volume":"581","author":"MQ Liao","year":"2007","unstructured":"Liao MQ, Tzeng YJ, Chang LY et al (2007) The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett 581:1161\u20131165","journal-title":"FEBS Lett"},{"key":"614_CR44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267\u2013298","journal-title":"Annu Rev Neurosci"},{"key":"614_CR45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"614_CR46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46:860\u2013866","journal-title":"Ann Neurol"},{"key":"614_CR47","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","volume":"158","author":"J Wang","year":"1999","unstructured":"Wang J, Dickson DW, Trojanowski JQ et al (1999) The levels of soluble versus insoluble brain Abeta distinguish Alzheimer\u2019s disease from normal and pathologic aging. Exp Neurol 158:328\u2013337","journal-title":"Exp Neurol"},{"key":"614_CR48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0959-9673.2005.00428.x","volume":"86","author":"M Tabaton","year":"2005","unstructured":"Tabaton M, Piccini A (2005) Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer\u2019s disease. Int J Exp Pathol 86:139\u2013145","journal-title":"Int J Exp Pathol"},{"key":"614_CR49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/74656","volume":"6","author":"DC Lu","year":"2000","unstructured":"Lu DC, Rabizadeh S, Chandra S et al (2000) A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 6:397\u2013404","journal-title":"Nat Med"},{"key":"614_CR50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.1168979","volume":"323","author":"G Di Fede","year":"2009","unstructured":"Di Fede G, Catania M, Morbin M et al (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323:1473\u20131477","journal-title":"Science"},{"key":"614_CR51","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(95)91556-7","volume":"346","author":"K Ritchie","year":"1995","unstructured":"Ritchie K, Kildea D (1995) Is senile dementia \u201cage-related\u201d or \u201cageing-related\u201d? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 346:931\u2013934","journal-title":"Lancet"},{"key":"614_CR52","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/ije\/21.4.763","volume":"21","author":"K Ritchie","year":"1992","unstructured":"Ritchie K, Kildea D, Robine JM (1992) The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data. Int J Epidemiol 21:763\u2013769","journal-title":"Int J Epidemiol"},{"key":"614_CR53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.44.2.250","volume":"44","author":"TF Wernicke","year":"1994","unstructured":"Wernicke TF, Reischies FM (1994) Prevalence of dementia in old age: clinical diagnoses in subjects aged 95\u00a0years and older. Neurology 44:250\u2013253","journal-title":"Neurology"},{"key":"614_CR54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0022-510X(92)90047-O","volume":"108","author":"T Mizutani","year":"1992","unstructured":"Mizutani T, Shimada H (1992) Neuropathological background of twenty-seven centenarian brains. J Neurol Sci 108:168\u2013177","journal-title":"J Neurol Sci"},{"key":"614_CR55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2190\/XKG9-YP7Y-QJTK-BGPG","volume":"45","author":"SM Samuelsson","year":"1997","unstructured":"Samuelsson SM, Alfredson BB, Hagberg B et al (1997) The Swedish Centenarian Study: a multidisciplinary study of five consecutive cohorts at the age of 100. Int J Aging Hum Dev 45:223\u2013253","journal-title":"Int J Aging Hum Dev"},{"key":"614_CR56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(98)00050-1","volume":"157","author":"Y Itoh","year":"1998","unstructured":"Itoh Y, Yamada M, Suematsu N, Matsushita M, Otomo E (1998) An immunohistochemical study of centenarian brains: a comparison. J Neurol Sci 157:73\u201381","journal-title":"J Neurol Sci"},{"key":"614_CR57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00006842-200205000-00014","volume":"64","author":"MH Silver","year":"2002","unstructured":"Silver MH, Newell K, Brady C, Hedley-White ET, Perls TT (2002) Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom Med 64:493\u2013501","journal-title":"Psychosom Med"},{"key":"614_CR58","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2788.2006.00842.x","volume":"50","author":"A Coppus","year":"2006","unstructured":"Coppus A, Evenhuis H, Verberne GJ et al (2006) Dementia and mortality in persons with Down\u2019s syndrome. J Intellect Disabil Res 50:768\u2013777","journal-title":"J Intellect Disabil Res"},{"key":"614_CR59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2007-11110","volume":"11","author":"E Head","year":"2007","unstructured":"Head E, Lott IT, Patterson D, Doran E, Haier RJ (2007) Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention. J Alzheimers Dis 11:61\u201376","journal-title":"J Alzheimers Dis"},{"key":"614_CR60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ana.410230206","volume":"23","author":"R Katzman","year":"1998","unstructured":"Katzman R, Terry R, DeTeresa R et al (1998) Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138\u2013144","journal-title":"Ann Neurol"},{"key":"614_CR61","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z et al (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837\u20131844","journal-title":"Neurology"},{"key":"614_CR62","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1076\/jcen.25.5.594.14582","volume":"25","author":"JH Lee","year":"2003","unstructured":"Lee JH (2003) Genetic evidence for cognitive reserve: variations in memory and related cognitive functions. J Clin Exp Neuropsychol 25:594\u2013613","journal-title":"J Clin Exp Neuropsychol"},{"key":"614_CR63","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archneurol.2010.178","volume":"67","author":"O Bugiani","year":"2010","unstructured":"Bugiani O, Giaccone G, Rossi G et al (2010) Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 67:987\u2013995","journal-title":"Arch Neurol"},{"key":"614_CR64","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm0498-452","volume":"4","author":"R Crook","year":"1998","unstructured":"Crook R, Verkkoniemi A, Perez-Tur J et al (1998) A variant of Alzheimer\u2019s disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med 4:452\u2013455","journal-title":"Nat Med"},{"key":"614_CR65","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/brain\/awm213","volume":"130","author":"S Alladi","year":"2007","unstructured":"Alladi S, Xuereb J, Bak T et al (2007) Focal cortical presentations of Alzheimer\u2019s disease. Brain 130:2636\u20132645","journal-title":"Brain"},{"key":"614_CR66","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.21451","volume":"64","author":"CD Rabinovici","year":"2008","unstructured":"Rabinovici CD, Jagust WJ, Furst AJ et al (2008) Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64:388\u2013401","journal-title":"Ann Neurol"},{"key":"614_CR67","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/WNL.0b013e3181d52785","volume":"74","author":"AC Bruni","year":"2010","unstructured":"Bruni AC, Bernardi L, Colao R et al (2010) Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology 74:798\u2013806","journal-title":"Neurology"},{"key":"614_CR68","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jnen\/63.3.199","volume":"63","author":"G Marcon","year":"2004","unstructured":"Marcon G, Giaccone G, Cupidi C et al (2004) Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol 63:199\u2013209","journal-title":"J Neuropathol Exp Neurol"},{"key":"614_CR69","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jnnp.74.6.715","volume":"74","author":"PM Kemp","year":"2003","unstructured":"Kemp PM, Holmes C, Hoffmann SM et al (2003) Alzheimer\u2019s disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 74:715\u2013719","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"614_CR70","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrn2420","volume":"9","author":"J G\u00f6tz","year":"2008","unstructured":"G\u00f6tz J, Ittner LM (2008) Animal models of Alzheimer\u2019s disease and frontotemporal dementia. Nat Rev Neurosci 9:532\u2013544","journal-title":"Nat Rev Neurosci"},{"key":"614_CR71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2010-1285","volume":"19","author":"E Di Maria","year":"2010","unstructured":"Di Maria E, Cammarata S, Parodi MI et al (2010) The H1 haplotype of the Tau gene (MAPT) is associated with mild cognitive impairment. J Alzheimers Dis 19:909\u2013914","journal-title":"J Alzheimers Dis"},{"key":"614_CR72","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/hmg\/ddi241","volume":"14","author":"AJ Myers","year":"2005","unstructured":"Myers AJ, Kaleem M, Marlowe L et al (2005) The H1c haplotype at the MAPT locus is associated with Alzheimer\u2019s disease. Hum Mol Genet 14:2399\u20132404","journal-title":"Hum Mol Genet"},{"key":"614_CR73","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.nbd.2006.10.018","volume":"25","author":"AJ Myers","year":"2007","unstructured":"Myers AJ, Pittman AM, Zhao AS et al (2007) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25:561\u2013570","journal-title":"Neurobiol Dis"},{"key":"614_CR74","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1471-4159.2005.03641.x","volume":"96","author":"SD Ginsberg","year":"2006","unstructured":"Ginsberg SD, Che S, Counts SE, Mufson EJ (2006) Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer\u2019s disease. J Neurochem 96:1401\u20131408","journal-title":"J Neurochem"},{"key":"614_CR75","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00005072-199655100-00001","volume":"55","author":"RD Terry","year":"1996","unstructured":"Terry RD (1996) The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 55:1023\u20131025","journal-title":"J Neuropathol Exp Neurol"},{"key":"614_CR76","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0197-4580(00)00216-5","volume":"21","author":"T Arendt","year":"2005","unstructured":"Arendt T (2005) Alzheimer\u2019s disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol Aging 21:783\u2013796","journal-title":"Neurobiol Aging"},{"key":"614_CR77","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1037\/0894-4105.19.4.520","volume":"19","author":"L B\u00e4ckman","year":"2005","unstructured":"B\u00e4ckman L, Jones S, Berger AK, Laukka EJ, Small BJ (2005) Cognitive impairment in preclinical Alzheimer\u2019s disease: a meta-analysis. Neuropsychology 19:520\u2013531","journal-title":"Neuropsychology"},{"key":"614_CR78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1073\/pnas.2634794100","volume":"101","author":"K Jin","year":"2004","unstructured":"Jin K, Peel AL, Mao XO et al (2004) Increased hippocampal neurogenesis in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 101:343\u2013347","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR79","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/nen.0b013e318160c5db","volume":"67","author":"B Li","year":"2008","unstructured":"Li B, Yamamori H, Tatebayashi Y et al (2008) Failure of neuronal maturation in Alzheimer disease dentate gyrus. J Neuropathol Exp Neurol 67:78\u201384","journal-title":"J Neuropathol Exp Neurol"},{"key":"614_CR80","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1101\/gad.13.21.2801","volume":"13","author":"DB Donoviel","year":"1999","unstructured":"Donoviel DB, Hadjantonakis AK, Ikeda M, Zheng H, Hyslop PS, Bernstein A (1999) Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev 13:2801\u20132810","journal-title":"Genes Dev"},{"key":"614_CR81","doi-asserted-by":"crossref","first-page":"23806","DOI":"10.1074\/jbc.M109.026328","volume":"284","author":"P Porayette","year":"2009","unstructured":"Porayette P, Gallego MJ, Kaltcheva MM, Vadakkadath Meethal S, Atwood CS (2009) Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells. J Biol Chem 284:23806\u201323817","journal-title":"J Biol Chem"},{"key":"614_CR82","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1523\/JNEUROSCI.4701-07.2007","volume":"27","author":"TL Young-Pearse","year":"2007","unstructured":"Young-Pearse TL, Bai J, Chang R, Zheng JB, LoTurco JJ, Selkoe DJ (2007) A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci 27:14459\u201314469","journal-title":"J Neurosci"},{"key":"614_CR83","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature07767","volume":"457","author":"A Nikolaev","year":"2009","unstructured":"Nikolaev A, McLaughlin T, O\u2019Leary DD, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981\u2013989","journal-title":"Nature"},{"key":"614_CR84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1096-9861(19990719)410:1<126::AID-CNE11>3.0.CO;2-5","volume":"410","author":"R Spreafico","year":"1999","unstructured":"Spreafico R, Arcelli P, Frassoni C et al (1999) Development of layer I of the human cerebral cortex after midgestation: architectonic findings, immunocytochemical identification of neurons and glia, and in situ labeling of apoptotic cells. J Comp Neurol 410:126\u2013142","journal-title":"J Comp Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0614-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-011-0614-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0614-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T18:44:29Z","timestamp":1560192269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-011-0614-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,13]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1007\/s10072-011-0614-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,13]]}}}